litlas
Log inCreate account

Leo Sachs

Active 1952–2006

96
Papers
18,423
Citations
84
h-index
96
i10-index

Citations

Citations per year for Leo Sachs1966: 20 citations1967: 25 citations1968: 28 citations1969: 41 citations1970: 66 citations1971: 128 citations1972: 124 citations1973: 154 citations1974: 111 citations1975: 84 citations1976: 113 citations1977: 109 citations1978: 173 citations1979: 88 citations1980: 135 citations1981: 118 citations1982: 59 citations1983: 86 citations1984: 51 citations1985: 41 citations1986: 49 citations1987: 63 citations1988: 33 citations1989: 45 citations1990: 68 citations1991: 72 citations1992: 99 citations1993: 144 citations1994: 156 citations1995: 200 citations1996: 205 citations1997: 136 citations1998: 102 citations1999: 120 citations2000: 81 citations2001: 75 citations2002: 125 citations2003: 81 citations2004: 74 citations2005: 75 citations2006: 59 citations2007: 62 citations2008: 59 citations2009: 51 citations2010: 45 citations2011: 34 citations2012: 31 citations2013: 22 citations2014: 26 citations2015: 32 citations2016: 24 citations2017: 17 citations2018: 22 citations2019: 69 citations2020: 56 citations2021: 49 citations2022: 38 citations2023: 24 citations2024: 40 citations2025: 12 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,529 citing papers, 42.3% of this breakdownUnited Kingdom: 270 citing papers, 7.5% of this breakdownIsrael: 209 citing papers, 5.8% of this breakdownFrance: 160 citing papers, 4.4% of this breakdownJapan: 156 citing papers, 4.3% of this breakdownGermany: 145 citing papers, 4% of this breakdownCanada: 140 citing papers, 3.9% of this breakdownChina: 121 citing papers, 3.3% of this breakdownAustralia: 117 citing papers, 3.2% of this breakdownItaly: 90 citing papers, 2.5% of this breakdownSweden: 77 citing papers, 2.1% of this breakdownNetherlands: 57 citing papers, 1.6% of this breakdown
0%42.3%Other 15.1%

Institutions

Fields

  • Biochemistry, Genetics and Molecular Biology44%
  • Medicine40.8%
  • Immunology and Microbiology6.4%
  • Pharmacology, Toxicology and Pharmaceutics2.4%
  • Agricultural and Biological Sciences1.6%
  • Neuroscience1.4%
  • Other3.4%

Topics

  • Cancer-related Molecular Pathways6.6%
  • Cell death mechanisms and regulation4.3%
  • Cancer Research and Treatments2.4%
  • Acute Myeloid Leukemia Research2.2%
  • Virus-based gene therapy research1.8%
  • Carcinogens and Genotoxicity Assessment1.7%
  • Other81%

Coauthors

All papers

Open in search
  1. NQO1 stabilizes p53 through a distinct pathway

    Authors: Gad Asher, Joseph Lotem, Rachel Kama, Leo Sachs, Yosef Shaul - National Academy of Sciences, Proceedings of the National Academy of Sciences 2002 cited by 289

  2. Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6

    Authors: Elisheva Yonish-Rouach, Dalia Resnftzky, Joseph Lotem, Leo Sachs, Adi Kimchi, Moshe Oren - Nature 1991 cited by 2,105

  3. Regulation of p53 stability and p53-dependent apoptosis by NADH quinone oxidoreductase 1

    Authors: Gad Asher, Joseph Lotem, Batya Cohen, Leo Sachs, Yosef Shaul - National Academy of Sciences, Proceedings of the National Academy of Sciences 2001 cited by 299

  4. Inhibition of NAD(P)H:quinone oxidoreductase 1 activity and induction of p53 degradation by the natural phenolic compound curcumin

    Authors: Peter Tsvetkov, Gad Asher, Veronica Reiss, Yosef Shaul, Leo Sachs, Joseph Lotem - National Academy of Sciences, Proceedings of the National Academy of Sciences 2005 cited by 154

  5. Epigenetics and the plasticity of differentiation in normal and cancer stem cells

    Authors: Joseph Lotem, Leo Sachs - Oncogene 2006 cited by 94

  6. Identification of mutagenic metabolites of benzo(a)pyrene in mammalian cells.

    Authors: Eliezer Huberman, Leo Sachs, Shen K. Yang, V Gelboin - National Academy of Sciences, Proceedings of the National Academy of Sciences 1976 cited by 480

  7. Hematopoietic cells from mice deficient in wild-type p53 are more resistant to induction of apoptosis by some agents

    Authors: Joseph Lotem, Leo Sachs - Blood 1993 cited by 301

  8. The cloning of normal “Mast” cells in tissue culture

    Authors: D H Pluznik, Leo Sachs - Journal of Cellular and Comparative Physiology 1965 cited by 882

  9. In vitro control of the development of macrophage and granulocyte colonies.

    Authors: Y Ichikawa, D H Pluznik, Leo Sachs - National Academy of Sciences, Proceedings of the National Academy of Sciences 1966 cited by 381

  10. Lysosomal destabilization in p53-induced apoptosis

    Authors: Xi Yuan, Wei Li, Helge Dalen, Joseph Lotem, Rachel Kama, Leo Sachs, Ulf T. Brunk - National Academy of Sciences, Proceedings of the National Academy of Sciences 2002 cited by 228

  11. Mdm-2 and ubiquitin-independent p53 proteasomal degradation regulated by NQO1

    Authors: Gad Asher, Joseph Lotem, Leo Sachs, Chaim Kahana, Yosef Shaul - National Academy of Sciences, Proceedings of the National Academy of Sciences 2002 cited by 219

  12. The myeloid blood cell differentiation-inducing protein MGI-2A is interleukin-6

    Authors: Y Shabo, Joseph Lotem, Menachem Rubinstein, M Revel, SC Clark, SF Wolf, Robert Kamen, Leo Sachs - Blood 1988 cited by 195

  13. Participation of myeloid leukaemic cells injected into embryos in haematopoietic differentiation in adult mice

    Authors: E. Gootwine, Cynthia Webb, Leo Sachs - Nature 1982 cited by 109

  14. THE DIFFERENTIATION OF MYELOID LEUKAEMIA CELLS: NEW POSSIBILITIES FOR THERAPY

    Authors: Leo Sachs - British Journal of Haematology 1978 cited by 162

  15. The control of hematopoiesis and leukemia: from basic biology to the clinic.

    Authors: Leo Sachs - National Academy of Sciences, Proceedings of the National Academy of Sciences 1996 cited by 139

  16. Cellular oxidative stress and the control of apoptosis by wild-type p53, cytotoxic compounds, and cytokines.

    Authors: Joseph Lotem, Mira Peled-Kamar, Yoram Groner, Leo Sachs - National Academy of Sciences, Proceedings of the National Academy of Sciences 1996 cited by 138

  17. Cell susceptibility to transformation and cytotoxicity by the carcinogenic hydrocarbon benzo[a]pyrene.

    Authors: Eliezer Huberman, Leo Sachs - National Academy of Sciences, Proceedings of the National Academy of Sciences 1966 cited by 114

  18. Regulation of megakaryocyte development by interleukin-6

    Authors: Joseph Lotem, Y Shabo, Leo Sachs - Blood 1989 cited by 113

  19. Genetic dissection of the control of normal differentiation in myeloid leukemic cells

    Authors: Joseph Lotem, Leo Sachs - National Academy of Sciences, Proceedings of the National Academy of Sciences 1977 cited by 95

  20. Suppression or induction of apoptosis by opposing pathways downstream from calcium-activated calcineurin

    Authors: Joseph Lotem, Rachel Kama, Leo Sachs - National Academy of Sciences, Proceedings of the National Academy of Sciences 1999 cited by 76

  21. Control of normal cell differentiation and the phenotypic reversion of malignancy in myeloid leukaemia

    Authors: Leo Sachs - Nature 1978 cited by 594

  22. INTERACTION OF THE CARBOHYDRATE-BINDING PROTEIN CONCANAVALIN A WITH NORMAL AND TRANSFORMED CELLS

    Authors: Michael Inbar, Leo Sachs - National Academy of Sciences, Proceedings of the National Academy of Sciences 1969 cited by 527

  23. In Vitro Transformation of Normal Cells to Tumor Cells by Carcinogenic Hydrocarbons2

    Authors: Yoheved Berwald, Leo Sachs - JNCI Journal of the National Cancer Institute 1965 cited by 395

  24. The induction of clones of normal mast cells by a substance from conditioned medium

    Authors: D H Pluznik, Leo Sachs - Experimental Cell Research 1966 cited by 356